TABLE OF CONTENTS
Volume 31, Issue 7 (April (1) 2003)
Mini Reviews |
Stem Cell Donation |
Allogeneic Transplant |
Autologous Transplant |
Graft-Versus-Host Disease |
Post-Transplant Complications |
Psychological Issues |
Psychosocial Issues |
Case Report |
Correspondence
Special Report
The promise of hematopoietic stem cell transplantation for autoimmune diseases FREE
R K Burt, A E Traynor, R Craig and A M Marmont
Bone Marrow Transplant 31: 521-524; doi:10.1038/sj.bmt.1703868
Mini Reviews
Should we continue to study high-dose chemotherapy in metastatic breast cancer patients? A critical review of the published data FREE
A Tartarone, G Romano, R Galasso, G Iodice, G D'Arena, M Coccaro, A Bochicchio, A Sgambato and N Di Renzo
Bone Marrow Transplant 31: 525-530; doi:10.1038/sj.bmt.1703824
Transformed lymphoma: an Achilles' heel of non-Hodgkin's lymphoma FREE
R E Lerner and L J Burns
Bone Marrow Transplant 31: 531-537; doi:10.1038/sj.bmt.1703875
Stem Cell Donation
Informed Consent – suggested procedures for informed consent for unrelated haematopoietic stem cell donors at various stages of recruitment, donor evaluation, and donor workup FREE
A Rosenmayr, L Hartwell and T Egeland on behalf of the Ethics Working Group of the World Marrow Donor Association
Bone Marrow Transplant 31: 539-545; doi:10.1038/sj.bmt.1703851
Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies FREE
L Krishnamurti, S Abel, M Maiers and S Flesch
Bone Marrow Transplant 31: 547-550; doi:10.1038/sj.bmt.1703887
Allogeneic Transplant
Reduced-intensity rituximab-BEAM-CAMPATH allogeneic haematopoietic stem cell transplantation for follicular lymphoma is feasible and induces durable molecular remissions FREE
A Y L Ho, S Devereux, G J Mufti and A Pagliuca
Bone Marrow Transplant 31: 551-557; doi:10.1038/sj.bmt.1703898
Autologous Transplant
High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients FREE
X Durando, J-J Lemaire, J Tortochaux, I Van-Praagh, F Kwiatkowski, C Vincent, C Bailly, P Verrelle, B Irthum, J Chazal and J-O Bay
Bone Marrow Transplant 31: 559-564; doi:10.1038/sj.bmt.1703889
Factors associated with survival in patients with progressive disease following autologous transplant for lymphoma FREE
O Paltiel, C Rubinstein, R Or, A Nagler, L Gordon, L Deutsch, A Polliack and E Naparstek
Bone Marrow Transplant 31: 565-569; doi:10.1038/sj.bmt.1703888
Occult tumor cells detected in autologous blood stem cell harvests have no impact on 5 year outcomes for breast cancer patients with 4–9 positive nodes treated with adjuvant high-dose therapy and stem cell transplantation FREE
E Reed, A Kessinger, B Murphy, S Tarantolo, M Traystman and J Graham Sharp
Bone Marrow Transplant 31: 571-574; doi:10.1038/sj.bmt.1703878
Graft-Versus-Host Disease
Recipient mHag-HA1 disparity and aGVHD in thalassemic-transplanted patients FREE
S Nesci, O Buffi, A Iliescu, M Andreani and G Lucarelli
Bone Marrow Transplant 31: 575-578; doi:10.1038/sj.bmt.1703880
Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease FREE
Y Ogawa, S Okamoto, T Mori, M Yamada, Y Mashima, R Watanabe, M Kuwana, K Tsubota, Y Ikeda and Y Oguchi
Bone Marrow Transplant 31: 579-583; doi:10.1038/sj.bmt.1703862
Post-Transplant Complications
Electrocardiogram is very useful for predicting acute heart failure following myeloablative chemotherapy with hematopoietic stem cell transplantation rescue FREE
M Akahori, H Nakamae, M Hino, T Yamane, T Hayashi, K Ohta, N Tatsumi, S Kitagawa and K Tsumura
Bone Marrow Transplant 31: 585-590; doi:10.1038/sj.bmt.1703890
Recombinant tissue plasminogen activator for treatment of hepatic veno-occlusive disease following bone marrow transplantation in children: effectiveness and a scoring system for initiating treatment FREE
R P S Bajwa, A J Cant, M Abinun, T J Flood, S Hodges, J P Hale and R Skinner
Bone Marrow Transplant 31: 591-597; doi:10.1038/sj.bmt.1703881
Psychological Issues
Neuropsychological outcome in long-term survivors of a childhood extracranial solid tumor who have undergone autologous bone marrow transplantation FREE
P Notteghem, C Soler, G Dellatolas, V Kieffer-Renaux, D Valteau-Couanet, G Raimondo and O Hartmann
Bone Marrow Transplant 31: 599-606; doi:10.1038/sj.bmt.1703882
Psychosocial Issues
Home care for children following haematopoietic stem cell transplantation FREE
M Miano, L Manfredini, A Garaventa, S Fieramosca, R Tanasini, G Morreale, C Manzitti and G Dini
Bone Marrow Transplant 31: 607-610; doi:10.1038/sj.bmt.1703892
Case Report
Stable molecular remission induced by imatinib mesylate (STI571) in a patient with CML lymphoid blast crisis relapsing after allogeneic stem cell transplantation FREE
B Wassmann, U Scheuring, C Thiede, H Pfeifer, M Bornhäuser, F Griesinger, A Hochhaus, E Schleyer, H Gschaidmeier, D Hoelzer and O G Ottmann
Bone Marrow Transplant 31: 611-614; doi:10.1038/sj.bmt.1703885
Correspondence
Successful application of epidermal growth factor for treatment of hemorrhagic cystitis after bone marrow transplantation FREE
E Dorticós, V Pavón, J C Jaime, M Reboredo, P López Saura, J Berlanga and P Hernández
Bone Marrow Transplant 31: 615-616; doi:10.1038/sj.bmt.1703877
Toxoplasmosis following allogeneic hematopoietic stem cell transplantation FREE
Rodrigo Martino and Catherine Cordonnier For the European Group for Blood and Marrow Transplantation Infectious Diseases Working Party (EBMT-IDWP)
Bone Marrow Transplant 31: 617-618; doi:10.1038/sj.bmt.1703914
Response to Martino and Cordonnier FREE
C C Kibbler, A Mele, P J Paterson and H G Prentice
Bone Marrow Transplant 31: 619; doi:10.1038/sj.bmt.1703915
